Stromectol and Mectizan: Understanding the Brand Names

Stromectol and Mectizan are two well-known brand names associated with the active ingredient ivermectin. Both contain the same active substance, but they have been used in different contexts.

Stromectol is the brand name under which oral ivermectin tablets have been marketed for human use in many countries. It is the formulation commonly referenced in clinical and pharmaceutical settings for individual patient treatment.

Mectizan is the brand name used primarily in large-scale public health programmes. Through the Mectizan Donation Program established by Merck, the medicine has been distributed free of charge for the control and elimination of onchocerciasis and, in combination with other medicines, for lymphatic filariasis.

Regardless of the brand name, the active compound remains ivermectin, a semi-synthetic derivative of the avermectins. Treatment decisions, dosage, and duration should always be determined by a qualified healthcare professional based on the specific medical condition and individual patient factors.

Understanding the distinction between these brand names helps clarify how ivermectin has been applied both in clinical practice and in large-scale global health initiatives over the past several decades.